Nrxn1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
NRXN1 Protein [1]
NRXN1 (Neurexin-1) encodes a polymorphic cell surface protein that functions as a critical synaptic adhesion molecule at presynaptic terminals. It mediates synaptic partner recognition and adhesion with postsynaptic neuroligins, playing a fundamental role in synapse formation, maintenance, and function. NRXN1 contains multiple protein domains including LNS domains, EGF-like repeats, and PDZ-binding motifs that facilitate diverse protein-protein interactions. Heterozygous deletions and mutations in NRXN1 are associated with autism spectrum disorder, intellectual disability, and schizophrenia, highlighting its essential role in normal neurodevelopment. Research into NRXN1 dysfunction may provide insights into synaptic mechanisms underlying neurodegenerative processes. [2]
Neurexin-1 is a polymorphic cell surface protein that functions as a synaptic adhesion molecule. It contains an extracellular domain with multiple LNS (Laminin/Neurexin/Sex hormone-binding globulin) domains and EGF-like repeats, a transmembrane region, and a cytoplasmic tail with PDZ-binding motifs. As a presynaptic protein, NRXN1 mediates recognition and adhesion with postsynaptic neuroligins.
Neurexin-1 is a polymorphic cell surface protein that functions as a synaptic adhesion molecule. It contains an extracellular domain with multiple LNS (Laminin/Neurexin/Sex hormone-binding globulin) domains and EGF-like repeats, a transmembrane region, and a cytoplasmic tail with PDZ-binding motifs. As a presynaptic protein, NRXN1 mediates recognition and adhesion with postsynaptic neuroligins.
NRXN1 haploinsufficiency leads to defective synapse formation and function, contributing to neurodevelopmental disorders. Altered neurexin-neuroligin interactions are implicated in the synaptic pathology of neurodegenerative diseases.
Current approaches focus on developing small molecules that can stabilize or enhance neurexin-neuroligin interactions. Gene therapy approaches to restore NRXN1 expression are under investigation.
The study of Nrxn1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Sudhof et al. Synaptic Neurexins and Neuroligins in Brain Function and Neuropsychiatric Disorders (2022). 2022. ↩︎
Barrow et al. CNTNAP2 and Cortical Development (2021). 2021. ↩︎